RecruitingNot ApplicableNCT06894875

Effects of Lentil Protein Hydrolysate on Blood Pressure Control, Vascular Function and Exercise Performance

Examining the Safety and Tolerability of Lentil Protein Hydrolysate in Healthy Males and Females Whilst Exploring the Effects of a Dose Range on Blood Pressure Control and Vascular Function and Exercise Performance

Sponsor

Nuritas Ltd

Enrollment

48 participants

Start Date

Jun 24, 2025

Study Type

INTERVENTIONAL

Conditions

Exercise performance Exercise Blood Pressure Vasodilation Vascular Function in Healthy Volunteers Safety and Tolerability in Healthy Volunteers

Summary

Examining the safety and tolerability of Lentil Protein Hydrolysate in healthy males and females whilst exploring the effects of a dose range on blood pressure control and vascular function and exercise performance

Eligibility

Min Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Lentil protein hydrolysate and Placebo MCC micro-crystalline cellulose for people with blood pressure, exercise, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 45 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.